Oncologic imaging : urology / Seung Hyup Kim, Jeong Yeon Cho, editors
Contributor(s): Cho, Jeong Yeon,, editor literario | Kim, Seung Hyup,, editor literario
Material type:
E-bookPublisher: Berlin, Heidelberg : Springer, [2016]Copyright date: 2017Description: 1 recurso en línea (x, 260 páginas) : ilustraciones (algunas a color).ISBN: 3662452189; 9783662452189.Subject: Aparato urinario -- Cáncer
Online resources: Acceso a este recurso digital (usuarios Universidad Europea de Madrid)
| Item type | Current library | Collection | Call number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | RC280 .U74 O536 2016 EB (Browse shelf(Opens below)) | Acceso electrónico | eBook.20022279 |
SpringerLink
Preface; Contents; Contributors; 1: Renal Tumors; 1.1 Introduction; 1.2 Detection; 1.3 Characterization; 1.3.1 US; 1.3.1.1 Solid Renal Mass; 1.3.1.2 Cystic Renal Mass; 1.3.1.3 Doppler US and€Contrast-ƯEnhanced US; 1.3.2 CT; 1.3.2.1 Unenhanced CT; 1.3.2.2 Contrast Enhancement; 1.3.3 MRI; 1.3.3.1 Signal Intensity; 1.3.3.2 Contrast Enhancement; 1.3.3.3 Diffusion-Weighted Imaging (DWI); 1.3.4 Positron Emission Tomography; 1.3.5 Biopsy; 1.4 Malignant Renal Cell Tumors: Renal Cell Carcinoma; 1.4.1 Pathologic Consideration; 1.4.1.1 Clear Cell Renal Cell Carcinoma.
1.4.1.10 Nuclear Grading of RCC1.4.2 Imaging; 1.4.2.1 Staging; 1.4.2.2 Subtypes of RCC; Clear Cell RCC; Papillary RCC; Chromophobe RCC; Multilocular Cystic RCC; Collecting Duct Carcinoma; Renal Medullary Carcinoma; Mucinous Tubular and Spindle Cell Carcinoma; Xp11.2 Translocation-TFE3 Gene Fusion Carcinoma; Hereditary RCC Syndromes; 1.5 Benign Renal Cell Tumors; 1.5.1 Oncocytoma; 1.5.1.1 Pathologic Consideration; 1.5.1.2 Imaging; 1.5.2 Papillary Adenoma; 1.6 Metanephric Tumors; 1.6.1 Metanephric Adenoma; 1.6.1.1 Pathologic Consideration; 1.6.1.2 Imaging; 1.7 Mesenchymal Tumors.
1.4.1.2 Multilocular Cystic Renal Cell Carcinoma (Multilocular Cystic Neoplasm of Low Malignant Potential)1.4.1.3 Papillary RCC; 1.4.1.4 Chromophobe RCC; 1.4.1.5 Carcinoma of Collecting Duct of Bellini (Collecting Duct Carcinoma); 1.4.1.6 MiTF/TFE Family Translocation- Associated Carcinoma; 1.4.1.7 Mucinous Tubular and Spindle Cell Carcinoma; 1.4.1.8 Renal Cell Carcinoma Associated with End-Stage Renal Disease (ESRD); Acquired Cystic Disease-Associated Renal Cell Carcinoma; Clear Cell Papillary Renal Cell Carcinoma; 1.4.1.9 Unclassified Renal Cell Carcinoma.
1.7.1 Sarcoma1.7.1.1 Pathologic Consideration; Clear Cell Sarcoma of€Kidney; Malignant Rhabdoid Tumor; Other Malignant Mesenchymal Tumors; 1.7.1.2 Imaging; 1.7.2 Angiomyolipoma; 1.7.2.1 Pathologic Consideration; 1.7.2.2 Imaging; US; CT; MRI; 1.7.3 Epithelioid Angiomyolipoma; 1.7.3.1 Pathologic Consideration; 1.7.3.2 Imaging; 1.7.4 Rare Benign Renal Mesenchymal Tumors; 1.7.4.1 Pathologic Consideration; 1.7.4.2 Imaging; 1.8 Cystic Nephroma and€Mixed Mesenchymal and€Epithelial Tumors; 1.8.1 Pathologic Consideration; 1.8.2 Imaging; 1.9 Nephroblastoma.
1.9.1 Pathologic Consideration1.9.2 Imaging; 1.10 Neuroendocrine Tumors; 1.10.1 Pathologic Consideration; 1.10.2 Imaging; 1.11 Lymphoma; 1.11.1 Pathologic Consideration; 1.11.2 Imaging; 1.12 Metastatic Tumors; 1.12.1 Pathologic Consideration; 1.12.2 Imaging; 1.13 Therapeutic Considerations; 1.13.1 Active Surveillance of€Renal Tumor; 1.13.2 Ablation of€Renal Tumor; 1.13.2.1 Introduction; 1.13.2.2 Patient Selection and€Preparation; 1.13.2.3 Procedures; 1.13.2.4 Complications; 1.13.2.5 Follow-Up; 1.13.2.6 Outcomes; 1.13.3 Surgery; 1.13.3.1 Radical Nephrectomy.
Online resource; title from PDF title page (SpringerLink, viewed October 7, 2016).
There are no comments on this title.